# ゾルゲンスマ髄注

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4900404X2026). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4900404X2026
- **Product name (Japanese):** ゾルゲンスマ髄注
- **Active ingredient:** オナセムノゲン アベパルボベク
- **Strength / unit:** １患者当たり
- **Route:** Injection (注射薬)
- **Therapeutic category:** 49 Other tissue and cell function agents (その他の組織細胞機能用医薬品)
- **Manufacturer:** Novartis Pharma (ノバルティス ファーマ)
- **NHI price (reference only):** JPY 167077222 per １患者当たり
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4900404X2026
- **JSON:** https://www.nifujipharma.com/api/drugs/4900404X2026

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=%E3%82%BE%E3%83%AB%E3%82%B2%E3%83%B3%E3%82%B9%E3%83%9E%E9%AB%84%E6%B3%A8%20%2F%20YJ%204900404X2026#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with オナセムノゲン アベパルボベク

- [ゾルゲンスマ点滴静注](https://www.nifujipharma.com/drugs/4900404X1020) — １患者当たり, Novartis Pharma